Source - SMW
Societe Generale today reaffirms its sell investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price target at 1320p.

Related Charts

GlaxoSmithKline (GSK)

+11.25p (+0.74%)
delayed 08:58AM